IL-8 Antikörper (AA 23-99)
Kurzübersicht für IL-8 Antikörper (AA 23-99) (ABIN7156933)
Target
Alle IL-8 (IL8) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 23-99
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Interleukin-8 protein (23-99AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- IL-8 (IL8) (Interleukin 8 (IL8))
-
Andere Bezeichnung
- CXCL8
-
Hintergrund
-
Background: IL-8 is a chemotactic factor that attracts neutrophils, basophils, and T-cells, but not monocytes. It is also involved in neutrophil activation. It is released from several cell types in response to an inflammatory stimulus. IL-8(6-77) has a 5-10-fold higher activity on neutrophil activation, IL-8(5-77) has increased activity on neutrophil activation and IL-8(7-77) has a higher affinity to receptors CXCR1 and CXCR2 as compared to IL-8(1-77), respectively.
Aliases: (Ala-IL-8)77 antibody, (Ser-IL-8)72 antibody, 9E3 antibody, Beta thromboglobulin like protein antibody, C-X-C motif chemokine 8 antibody, CEF-4 antibody, chemokine, CXC motif, ligand 8 antibody, CXCL8 antibody, Emoctakin antibody, GCP-1 antibody, GCP/IL-8 protein I antibody, GCP/IL-8 protein II antibody, GCP/IL-8 protein III antibody, GCP/IL-8 protein IV antibody, GCP/IL-8 protein V antibody, GCP/IL-8 protein VI antibody, GCP1 antibody, Granulocyte chemotactic protein 1 antibody, IL-8 antibody, IL-8(1-77) antibody, IL-8(9-77) antibody, IL8 antibody, IL8/NAP1 form I antibody, IL8/NAP1 form II antibody, IL8/NAP1 form III antibody, IL8/NAP1 form IV antibody, IL8/NAP1 form V antibody, IL8/NAP1 form VI antibody, IL8_HUMAN antibody, Inteleukin 8 antibody, LECT antibody, LUCT antibody, Lymphocyte-derived neutrophil-activating factor antibody, LYNAP antibody, MDNCF antibody, MDNCF-b antibody, MDNCF-c antibody, MONAP antibody, Monocyte derived neutrophil activating peptide antibody, Monocyte derived neutrophil chemotactic factor antibody, Monocyte-derived neutrophil chemotactic factor antibody, Monocyte-derived neutrophil-activating peptide antibody, NAF antibody, NAP 1 antibody, NAP-1 antibody, NAP1 antibody, Neutrophil activating peptide 1 antibody, Neutrophil activating protein 1 antibody, Neutrophil-activating factor antibody, Neutrophil-activating protein 1 antibody, Protein 3 10C antibody, Protein 3-10C antibody, SCYB 8 antibody, SCYB8 antibody, Small inducible cytokine subfamily B member 8 antibody, T cell chemotactic factor antibody, T-cell chemotactic factor antibody, TSG 1 antibody, TSG1 antibody
-
UniProt
- P10145
-
Pathways
- TLR Signalweg, Cellular Response to Molecule of Bacterial Origin, Regulation of G-Protein Coupled Receptor Protein Signaling, ER-Nucleus Signaling, Hepatitis C, Autophagie
Target
-